Cargando…
Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease
OBJECTIVES: The aim of this study was to validate an active matrix metalloproteinase (MMP‐8) point‐of‐care diagnostic tool in COVID‐19 patients with periodontal disease. SUBJECTS, MATERIALS, AND METHODS: Seventy‐two COVID‐19‐positive and 30 COVID‐19‐negative subjects were enrolled in the study. Demo...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350191/ https://www.ncbi.nlm.nih.gov/pubmed/35818743 http://dx.doi.org/10.1002/cre2.589 |
_version_ | 1784762189773537280 |
---|---|
author | Gupta, Shipra Mohindra, Ritin Singla, Mohita Khera, Sagar Kumar, Amit Rathnayake, Nilminie Sorsa, Timo Pfützner, Andreas Räisänen, Ismo T. Soni, Roop K. Kanta, Poonam Jain, Akanksha Gauba, Krishan Goyal, Kapil Singh, Mini P. Ghosh, Arnab Kajal, Kamal Mahajan, Varun Suri, Vikas Bhalla, Ashish |
author_facet | Gupta, Shipra Mohindra, Ritin Singla, Mohita Khera, Sagar Kumar, Amit Rathnayake, Nilminie Sorsa, Timo Pfützner, Andreas Räisänen, Ismo T. Soni, Roop K. Kanta, Poonam Jain, Akanksha Gauba, Krishan Goyal, Kapil Singh, Mini P. Ghosh, Arnab Kajal, Kamal Mahajan, Varun Suri, Vikas Bhalla, Ashish |
author_sort | Gupta, Shipra |
collection | PubMed |
description | OBJECTIVES: The aim of this study was to validate an active matrix metalloproteinase (MMP‐8) point‐of‐care diagnostic tool in COVID‐19 patients with periodontal disease. SUBJECTS, MATERIALS, AND METHODS: Seventy‐two COVID‐19‐positive and 30 COVID‐19‐negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP‐8 (aMMP‐8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse‐based kit for general disease activity. In COVID‐19‐positive patients, the kits were run again once the patients turned COVID‐19 negative. RESULTS: The overall (n = 102) sensitivity/specificity of the mouthrinse‐based kits to detect periodontal disease was 79.41%/36.76% and that of site‐specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746–0.869 (p < .001) and 0.740–0.872 (p < .001) (the aMMP‐8 mouth rinse and site‐specific kits, respectively). No statistically significant difference was observed in the distribution of results of aMMP‐8 mouth rinse test (p = .302) and aMMP‐8 site‐specific test (p = .189) once the subjects recovered from COVID‐19. CONCLUSIONS: The findings of the present study support the aMMP‐8 point‐of‐care testing (PoCT) kits as screening tools for periodontitis in COVID‐19 patients. The overall screening accuracy can be further increased by utilizing adjunctively risk factors of periodontitis. The reported noninvasive, user‐friendly, and objective PoCT diagnostic methodology may provide a way of stratifying risk groups, deciding upon referrals, and in the institution of diligent oral hygiene regimens. |
format | Online Article Text |
id | pubmed-9350191 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93501912022-08-04 Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease Gupta, Shipra Mohindra, Ritin Singla, Mohita Khera, Sagar Kumar, Amit Rathnayake, Nilminie Sorsa, Timo Pfützner, Andreas Räisänen, Ismo T. Soni, Roop K. Kanta, Poonam Jain, Akanksha Gauba, Krishan Goyal, Kapil Singh, Mini P. Ghosh, Arnab Kajal, Kamal Mahajan, Varun Suri, Vikas Bhalla, Ashish Clin Exp Dent Res Original Articles OBJECTIVES: The aim of this study was to validate an active matrix metalloproteinase (MMP‐8) point‐of‐care diagnostic tool in COVID‐19 patients with periodontal disease. SUBJECTS, MATERIALS, AND METHODS: Seventy‐two COVID‐19‐positive and 30 COVID‐19‐negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP‐8 (aMMP‐8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse‐based kit for general disease activity. In COVID‐19‐positive patients, the kits were run again once the patients turned COVID‐19 negative. RESULTS: The overall (n = 102) sensitivity/specificity of the mouthrinse‐based kits to detect periodontal disease was 79.41%/36.76% and that of site‐specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746–0.869 (p < .001) and 0.740–0.872 (p < .001) (the aMMP‐8 mouth rinse and site‐specific kits, respectively). No statistically significant difference was observed in the distribution of results of aMMP‐8 mouth rinse test (p = .302) and aMMP‐8 site‐specific test (p = .189) once the subjects recovered from COVID‐19. CONCLUSIONS: The findings of the present study support the aMMP‐8 point‐of‐care testing (PoCT) kits as screening tools for periodontitis in COVID‐19 patients. The overall screening accuracy can be further increased by utilizing adjunctively risk factors of periodontitis. The reported noninvasive, user‐friendly, and objective PoCT diagnostic methodology may provide a way of stratifying risk groups, deciding upon referrals, and in the institution of diligent oral hygiene regimens. John Wiley and Sons Inc. 2022-07-11 /pmc/articles/PMC9350191/ /pubmed/35818743 http://dx.doi.org/10.1002/cre2.589 Text en © 2022 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Gupta, Shipra Mohindra, Ritin Singla, Mohita Khera, Sagar Kumar, Amit Rathnayake, Nilminie Sorsa, Timo Pfützner, Andreas Räisänen, Ismo T. Soni, Roop K. Kanta, Poonam Jain, Akanksha Gauba, Krishan Goyal, Kapil Singh, Mini P. Ghosh, Arnab Kajal, Kamal Mahajan, Varun Suri, Vikas Bhalla, Ashish Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease |
title | Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease |
title_full | Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease |
title_fullStr | Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease |
title_full_unstemmed | Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease |
title_short | Validation of a noninvasive aMMP‐8 point‐of‐care diagnostic methodology in COVID‐19 patients with periodontal disease |
title_sort | validation of a noninvasive ammp‐8 point‐of‐care diagnostic methodology in covid‐19 patients with periodontal disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350191/ https://www.ncbi.nlm.nih.gov/pubmed/35818743 http://dx.doi.org/10.1002/cre2.589 |
work_keys_str_mv | AT guptashipra validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT mohindraritin validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT singlamohita validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT kherasagar validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT kumaramit validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT rathnayakenilminie validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT sorsatimo validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT pfutznerandreas validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT raisanenismot validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT soniroopk validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT kantapoonam validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT jainakanksha validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT gaubakrishan validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT goyalkapil validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT singhminip validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT ghosharnab validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT kajalkamal validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT mahajanvarun validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT surivikas validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease AT bhallaashish validationofanoninvasiveammp8pointofcarediagnosticmethodologyincovid19patientswithperiodontaldisease |